Explore comprehensive CDMO services offered by RoslinCT, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. RoslinCT enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A., United Kingdom
Description: RoslinCT is a global Contract Development and Manufacturing Organization (CDMO) specializing in advanced cell and gene therapies. Founded in 2006 and built on technology from the cloning of Dolly the Sheep at the Roslin Institute, the company provides services like process development, GMP manufacturing, analytical development, and cryopreservation for cell-based therapies. It operates licensed facilities in Scotland and Massachusetts and has a focus on helping partners bring therapies to market.
